About Winston Pharmaceuticals Limited
Data last updated:
Winston Pharmaceuticals Limited was a public limited company based in Aurangabad, Maharashtra, India, operated as a subsidiary of Reliv Healthcare Private Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 24 June 1996.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U24231MH1996PLC360820. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹6 Cr and a paid-up capital of ₹5.11 Cr. It was led by directors including Rajiv Kumar Sharma and Ranjana Sharma.
Its last annual general meeting (AGM) was held on 29 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office was at H – 19 MIDC Waluj, Aurangabad, Maharashtra, India – 431133.
As per the financials filed for FY 2023, the company reported a revenue of ₹3.85 Cr, a decline of 21% compared to the previous year. For the same year it recorded a net loss of ₹61.55 Lakh (net margin -16%) and EBITDA of -₹53.86 Lakh (EBITDA margin -14%). Revenue has declined at a compounded annual rate (CAGR) of 18% over three years and 13% over five years.
The company had about 58 employees on its provident fund (EPFO) records before it was dissolved.
As per MCA filings, the company had satisfied charges of ₹6.92 Cr on record. Court records list 3 cases involving the company, including 1 filed by the company and 2 filed against it; 2 cases are pending.
The last known website on record is winstonpharma.com.
Company details
CIN history
Winston Pharmaceuticals has one previous CIN (Corporate Identification Number): U24231UP1996PLC020204. The current CIN is U24231MH1996PLC360820, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231MH1996PLC360820 | Current |
| U24231UP1996PLC020204 | Previous |
Contact details
Winston Pharmaceuticals Limited's registered office is in Aurangabad, Maharashtra. Its website is winstonpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressH – 19 MIDC Waluj, Aurangabad, Maharashtra, India – 431133
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Winston Pharmaceuticals Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Winston Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Winston Pharmaceuticals Limited, buy the company report.
Financials of Winston Pharmaceuticals Limited
FY 2023 filings availableWinston Pharmaceuticals Limited reported revenue of ₹3.85 Cr (down 21% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 13% over five years, including a 21% fall in the latest year. EBITDA fell 61% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹53.86 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹61.55 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -14% | ||||
| Net Profit Margin | -16% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Winston Pharmaceuticals Limited, buy the company report.
Board of directors of Winston Pharmaceuticals Limited
Winston Pharmaceuticals has 4 current directors and 17 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajiv Kumar Sharma | Director | 26 Feb 2015 | 11 Years 8 Months | As last reported |
| Ranjana Sharma Also directs: RV Lifesciences Limited, RVLL Infrastructure Private Limited | Director | 12 Jan 2018 | 8 Years 9 Months | As last reported |
| Hitesh Premnath Bhandari Also directs: RV Lifesciences Limited, RVLL Infrastructure Private Limited | Director | 24 Dec 2020 | 5 Years 10 Months | As last reported |
| Rajesh Kumar Also directs: RV Lifesciences Limited, Octelle Impex Private Limited | Director | 24 Dec 2020 | 5 Years 10 Months | As last reported |
Peer comparison
Winston Pharmaceuticals Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nixies Pharmaceuticals Private Limited | ₹3.86 Cr (FY 2025) | 3.0% | Bhubaneswar, Odisha, India | |||
| Dzire Life Care Private Limited | ₹3.86 Cr (FY 2018) | -6.0% | Surat, Gujarat, India | |||
| Winston Pharmaceuticals Limitedthis company | ₹3.85 Cr (FY 2023) | -₹61.55 Lakh | -16% | -21.0% | 58 | Aurangabad, Maharashtra, India |
| BCM Healthcare Private Limited | ₹3.85 Cr (FY 2025) | 89.0% | Ahmedabad, Gujarat, India | |||
| Elegant Distributors Private Limited | ₹3.84 Cr (FY 2024) | 7.0% | Delhi, India | |||
| Udayam Pharmaceuticals Private Limited | ₹3.84 Cr (FY 2018) | -2.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Winston Pharmaceuticals Limited, buy the company report.
Auditor
Winston Pharmaceuticals Limited is audited by JIVAP & Associates for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JIVAP & Associates | FY 2022 | 026507N |
Shareholding
The shareholding of Winston Pharmaceuticals Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Winston Pharmaceuticals Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Jun 2017 | 100110618 | Others | ₹1.76 Cr | Satisfied | |
| 06 Jun 2016 | 100037258 | Hdfc Bank Limited | ₹1.98 Cr | Satisfied | |
| 30 Sep 2014 | 10529098 | Union Bank of India | ₹30 Lakh | Satisfied | |
| 26 Dec 2012 | 10403958 | Union Bank of India | ₹16.44 Lakh | Satisfied | |
| 25 Jan 2012 | 10336797 | Union Bank of India | ₹10 Lakh | Satisfied |
To see the full charge records of Winston Pharmaceuticals Limited, buy the company report.
Total charge records: 11 View all charges
Legal cases
Winston Pharmaceuticals Limited has 3 court cases on record: 1 filed by Winston Pharmaceuticals, 2 filed against it. 2 cases are pending and 1 is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 2 | 2 |
| NCLT | 1 | 0 | 0 |
Cases on record (2 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Allahabad High Court | Court case (NA528) | Filed against the company | Pending |
| NCLT, Mumbai | Court case (C.P.(CAA)) | Filed by the company | Disposed |
To see the full case history of Winston Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Winston Pharmaceuticals Limited has 4 MSME Form 1 returns on record between 2019 and 2021, listing 40 overdue payments to 4 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (4 of 4)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Orchid Bio-Tech Limited | |||
| an individual supplier | |||
| Skiros Healthcare | |||
| Adhya Pharmaceuticals Private Limited |
To see the full MSME payment records of Winston Pharmaceuticals Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Winston Pharmaceuticals Limited has a workforce of 58 employees on its EPFO records as of Mar 31, 2024, across 1 active EPFO establishment.
GST
Winston Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Winston Pharmaceuticals Limited, buy the company report.
Recent activity
Winston Pharmaceuticals Limited has 21 board changes on record since 2008: 4 appointments and 17 cessations. The latest: Dinesh Kumar Suri ceased to be Director on 23 Jan 2021.
38 earlier events are in the company report.
Frequently asked questions
Winston Pharmaceuticals has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Winston Pharmaceuticals was a public limited company based in Aurangabad, Maharashtra, India. The company worked in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 24 June 1996 and is registered under CIN U24231MH1996PLC360820. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Winston Pharmaceuticals was incorporated on 24 June 1996. It is registered with the Registrar of Companies, Mumbai.
Winston Pharmaceuticals had 4 directors:
- Rajiv Kumar Sharma - Director
- Ranjana Sharma - Director
- Hitesh Premnath Bhandari - Director
- Rajesh Kumar - Director
The CIN (Corporate Identification Number) of Winston Pharmaceuticals is U24231MH1996PLC360820. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Winston Pharmaceuticals is at H – 19 MIDC Waluj, Aurangabad, Maharashtra, India – 431133.
Winston Pharmaceuticals can be reached through the website winstonpharma.com. Its registered office is in Aurangabad, Maharashtra, India.
The latest financial statements of Winston Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 29 September 2023. Year-wise statements from 2015 are in the company report.
No. Winston Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
Winston Pharmaceuticals operated in the pharma industry, in the pharmaceutical retailers and distributors segment.
The peers of Winston Pharmaceuticals by revenue are Nixies Pharmaceuticals Private Limited, Dzire Life Care Private Limited, BCM Healthcare Private Limited, Elegant Distributors Private Limited, Udayam Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Winston Pharmaceuticals has 4 MSME Form 1 returns on record between 2019 and 2021, listing 40 overdue payments to 4 micro and small suppliers. The latest return was filed on 22 Oct 2021.